558
Views
21
CrossRef citations to date
0
Altmetric
Research Papers

ICF in neurology: Functioning and disability in patients with migraine, myasthenia gravis and Parkinson's disease

, , , , , , , , , , , , , , , & show all
Pages S88-S99 | Accepted 01 Sep 2009, Published online: 07 Dec 2009

References

  • Mathers CD, Bernard C, Moesgaard IK, Inoue M, Ma Fat D, Shibuya K, Stein C, Tomijima N, Xu H. Global burden of disease in 2002: data sources, methods and results. Geneva, World Health Organization, 2004 (GPE Discussion Paper No. 54, February 2004). Electronic Citation. http://www.who.int/healthinfo/paper54.pdf. Last accessed April 2009.
  • World Health Organization. Global burden of neurological disorders: estimates and projections. In: WHO. Neurological disorders: public health challenges. Geneva: WHO; 2007. pp 27–39.
  • Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005. 12(Suppl 1):1–27.
  • Leonardi M, Bickenbach J, Ustun TB, Kostanjek N, Chatterji S, on behalf of the MHADIE Consortium. The definition of disability: what is in a name? Lancet 2006;368:1219–1921.
  • Linacre JM, Heinemann AW, Wright BD, Granger CV, Hamilton BB. The structure and stability of the Functional Independence Measure. Arch Phys Med Rehabil 1994;75:127–132.
  • Binkley JM, Stratford PW, Lott SA, Riddle DL. The lower extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Rehabilitation Research Network. Phys Ther 1999;79:371–383.
  • Penta M, Thonnard JL, Tesio L. ABILHAND: a Rasch-built measure of manual ability. Arch Phys Med Rehabil 1998;79:1038–1042.
  • World Health Organization. The international classification of functioning, disability and health: ICF. Geneva: World Health Organization; 2001.
  • Ewert T, Fuessl M, Cieza A, Andersen C, Chatterji S, Kostanjsek N, Stucki G. Identification of the most common patient problems in patients with chronic conditions using the ICF checklist. J Rehabil Med 2004. 36(Suppl 44):22–29.
  • Cieza A, Ewert T, Ustun TB, Chatterji S, Kostanjsek N, Stucki G. Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med 2004;36(Suppl 44): 9–11.
  • Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun TB, Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med 2005;37:212–218.
  • Grill E, Lipp B, Boldt C, Stucki G, Koenig E. Identification of relevant ICF categories by patients with neurological conditions in early post-acute rehabilitation facilities. Disabil Rehabil 2005;27:459–465.
  • Wolfe GI, Herbelin LR, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology 1999;52:1487–1489.
  • Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1999;19:44–51.
  • Pathak DA, Chisolm DJ, Weis KA. Functional assessment in migraine (FAIM) questionnaire: development of an instrument based upon the WHO's international classification of functioning, disability, and health. Value Health 2005;8:591–600.
  • Fahn S, Elton RL. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Golstein N, editors. Recent developments in Parkinson's disease. Florham Park, NJ: MacMillan Health Care Information; 1987. pp 153–163.
  • Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IMI, editors. Third symposium on surgery in Parkinson's disease. Edinburg: Livingstone; 1969, pp 152–157.
  • Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Stud 1988;10:64–67.
  • Duke University Center for the Study of Aging and Human Development. Multidimensional functional assessment: the OARS methodology, a manual, 2nd ed. Durham, NC: Center for the Study of Aging and Human Development, Duke University; 1978.
  • D'Alessandro R, Casmiro M, Benassi G, Rinaldi R, Gamberoni G. Reliable disability scale for myasthenia gravis sensitive to clinical changes. Acta Neurol Scand 1995;92:77–82.
  • Guy-Coichard C, Bguyen DT, Delorme T, Boureau F. Pain in hereditary neuromuscular disorders and myasthenia gravis: a national survey of frequency, characteristics and impact. J Pain Symptom Manage 2008;35:40–50.
  • Lavrnic D, Vujic A, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Trikic R, Apostolski S. Cyclosporine in the treatment of myasthenia gravis. Acta Neurol Scand 2005;111:247–252.
  • Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, Steiner TJ, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193–210.
  • Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF. Migraine headache disability and health-related quality of life: a population-based case-control study from England. Cephalalgia 2003;23:441–450.
  • Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ. CARPA Study Group. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 2008;70:2241–2247.
  • Tanji H, Gruber-Baldini AL, Anderson KE, Pretzer-Aboff I, Reich SG, Fishman PS, Weiner WJ, Shulman LM. A comparative study of physical performance measures in Parkinson's disease. Mov Disord 2008;23:1897–1905.
  • Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's Disease. J Am Geriatr Soc 2004;52:784–788.
  • Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, Weiner WJ. The evolution of disability in Parkinson Disease. Mov Disord 2008;23:790–796.
  • Leonardi M, Bickenbach J, Raggi A, Sala M, Guzzon P, Valsecchi MR, Fusaro G, Russo E, Francescutti C, Nocentini U, Martinuzzi A. Training on the international classification of functioning, disability and health (ICF): the ICF-DIN basic and the ICF-DIN advanced course developed by the disability Italian network. J Headache Pain 2005;6:159–164.
  • Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 2007;5:56.
  • D'Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F, De Marco R, Massetto N, Bussone G. Progetto Cefalee Lombardia Group. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 2006;26:691–696.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.